Robert J Alpern - Net Worth and Insider Trading

Robert J Alpern Net Worth

The estimated net worth of Robert J Alpern is at least $0 dollars as of 2024-11-09. Robert J Alpern is the Director of Tricida Inc and owns about 0 shares of Tricida Inc (TCDAQ) stock worth over $0. Details can be seen in Robert J Alpern's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J Alpern has not made any transactions after 2022-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert J Alpern

To

Robert J Alpern Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert J Alpern owns 3 companies in total, including Abbott Laboratories (ABT) , AbbVie Inc (ABBV) , and Tricida Inc (TCDAQ) .

Click here to see the complete history of Robert J Alpern’s form 4 insider trades.

Insider Ownership Summary of Robert J Alpern

Ticker Comapny Transaction Date Type of Owner
ABT Abbott Laboratories 2008-10-10 director
ABBV AbbVie Inc 2019-09-30 director
TCDAQ Tricida Inc 2022-11-23 director

Robert J Alpern Latest Holdings Summary

Robert J Alpern currently owns a total of 1 stock. Robert J Alpern owns 0 shares of Tricida Inc (TCDAQ) as of November 23, 2022, with a value of $0.

Latest Holdings of Robert J Alpern

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCDAQ Tricida Inc 2022-11-23 0 0.00 0

Holding Weightings of Robert J Alpern


Robert J Alpern Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert J Alpern has made a total of 5 transactions in Tricida Inc (TCDAQ) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Tricida Inc is the sale of 131,879 shares on November 23, 2022, which brought Robert J Alpern around $27,695.

Insider Trading History of Robert J Alpern

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert J Alpern Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert J Alpern Ownership Network

Ownership Network List of Robert J Alpern

No Data

Ownership Network Relation of Robert J Alpern

Insider Network Chart

Robert J Alpern Owned Company Details

What does Abbott Laboratories do?

Who are the key executives at Abbott Laboratories?

Robert J Alpern is the director of Abbott Laboratories. Other key executives at Abbott Laboratories include Executive Vice President Hubert L Allen , Senior Vice President Robert B Ford , and VICE PRESIDENT Mccoy John A. Jr. .

Abbott Laboratories (ABT) Insider Trades Summary

Over the past 18 months, Robert J Alpern made no insider transaction in Abbott Laboratories (ABT). Other recent insider transactions involving Abbott Laboratories (ABT) include a net sale of 80,400 shares made by Andrea F Wainer , a net sale of 158,274 shares made by Hubert L Allen , and a net sale of 100,000 shares made by Daniel J Starks .

In summary, during the past 3 months, insiders sold 299,127 shares of Abbott Laboratories (ABT) in total and bought 0 shares, with a net sale of 299,127 shares. During the past 18 months, 524,935 shares of Abbott Laboratories (ABT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,935 shares.

Abbott Laboratories (ABT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Abbott Laboratories Insider Transactions

No Available Data

Robert J Alpern Mailing Address

Above is the net worth, insider trading, and ownership report for Robert J Alpern. You might contact Robert J Alpern via mailing address: Yale School Of Medicine, 333 Cedar Street, C203 Shm, New Haven Ct 06520.